Delivery Order SPE2DB22D1017-SPE2DB24FF1WQ
Award Date 1/25/24
Potential Completion Date 1/26/24
Potential Value $9.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,160.24 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens, with a period of performance ending on April 14, 2023. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ozempic 0.25-0.5 mg/dose pen 3 mL. The contract has a firm-fixed price of $7,328.68 and an ultimate completion date of January 12, 2024. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. (doing business as AmerisourceBergen) with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $6,702.93 for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 10, 2023. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical...
- This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $35,738.22, is for the delivery of Ozempic 0.25-0.5 mg/dose pens. The contract has a completion date of November 9, 2023 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Ozempic 0.25-0.5 mg/dose pens. The contract, valued at $11,074.96, is a firm-fixed-price delivery order with a completion date of February 5, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $30,768.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens in 1.5 mL quantities, with a completion date of March 13, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a $11,610.44 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Ozempic 0.25-0.5 mg/dose pens. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $9,907.33 delivery order contract is for the supply of the pharmaceutical product Ozempic (0.25-0.5 mg/dose pen 3 mL) and has a completion date of December 22, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a ceiling value of $9,872.97 and an ultimate completion date of December 18, 2023. The contract is a firm fixed-price delivery order, and it was not set aside for any specific business category. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,927.34, is for the delivery of the pharmaceutical product Ozempic in a 0.25-0.5 mg/dose pen with a 3 ml capacity. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 29, 2024. The contract was awarded on April 26, 2024 and did not have a set-aside designation, indicating it was awarded...